Results will be, are we a complete vaccine? 1) safe, 2) front end b-cell epitope, do we make antibodies that bind, 3) are we as good as usual making CD4, CD8, TCell activation for long term memory, if we do all 3 we are the only ones going into people in a phase one that can say this. Jury is out, good bad or indifferent we will know when we have those answers.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links